Amitriptyline or not, that is the question: pharmacogenetic testing of CYP2D6 and CYP2C19 identifies patients with low or high risk for side effects in amitriptyline therapy (Q45182394)
Jump to navigation
Jump to search
scientific article published on 8 December 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Amitriptyline or not, that is the question: pharmacogenetic testing of CYP2D6 and CYP2C19 identifies patients with low or high risk for side effects in amitriptyline therapy |
scientific article published on 8 December 2004 |
Statements
1 reference
Amitriptyline or not, that is the question: pharmacogenetic testing of CYP2D6 and CYP2C19 identifies patients with low or high risk for side effects in amitriptyline therapy (English)
1 reference
Werner Kissling
1 reference
Stefan Leucht
1 reference
Werner Steimer
1 reference
Konstanze Zöpf
1 reference
Silvia von Amelunxen
1 reference
Herbert Pfeiffer
1 reference
Julia Bachofer
1 reference
Johannes Popp
1 reference
Barbara Messner
1 reference
8 December 2004
1 reference
1 reference
51
1 reference
2
1 reference
376-385
1 reference
Identifiers
1 reference
1 reference